Life Science REIT PLC (LABS) — Cash Flow Reinvestment Rate
Life Science REIT PLC (LABS) has a Cash Flow Reinvestment Rate of 6.06x as of June 2025, reinvesting GBX5.81 Million (capex GBX5.81 Million ) from operating cash flow of GBX958.00K. Check LABS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Life Science REIT PLC Cash Flow Reinvestment Rate (2021–2024)
Historical reinvestment intensity for Life Science REIT PLC across 3 annual periods. Explore LABS strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Life Science REIT PLC (2021–2024)
Year-by-year capital reinvestment analysis for Life Science REIT PLC. For live market cap and broader valuation context, see Life Science REIT PLC (LABS) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.76x | GBX35.63 Million | GBX12.92 Million | GBX19.28 Million | ▼ -41.1% |
| 2023 | 4.69x | GBX35.68 Million | GBX7.62 Million | GBX24.03 Million | ▼ -91.2% |
| 2021 | 53.46x | GBX189.16 Million | GBX3.54 Million | GBX7.64 Million | — |